The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseases

被引：7

作者：

Lories, RJU ^{[1
]}

Maertens, JA ^{[1
]}

Ceuppens, JL ^{[1
]}

Peetermans, WE ^{[1
]}

机构：

[1] Catholic Univ Leuven, Univ Hosp, Dept Internal Med Rheumatol, Louvain, Belgium

来源：

ACTA CLINICA BELGICA | 2000年 / 55卷 / 03期

关键词：

D O I：

10.1080/17843286.2000.11754288

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this review we discuss the prevention and treatment of infectious diseases with intravenous immunoglobulins (IVIG). IVIG can be used to prevent infections in primary as well as in certain secondary immunodeficiencies. We also discuss the use of IVIG in the prevention of CMV-disease after organ or bone marrow transplantation. Besides their use in prevention, IVIG can also be used as an additional therapy in sepsis in neonates, in streptococcal toxic shock syndrome and in CMV-disease after bone marrow or solid organ transplantation. We briefly discuss the different preparations of IVIG that are available in Belgium.

引用

页码：163 / 169

页数：7

共 50 条

[21] THE IMPORTANCE OF INTRAVENOUS IMMUNOGLOBULINS IN THE TREATMENT OF ADULT HEMATOLOGICAL DISEASES
Glaser, Marjana
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 (6-7): : 447 - 451
[22] INTRAVENOUS IMMUNOGLOBULINS (IVIG) IN THE TREATMENT OF AUTOIMMUNE-DISEASES
KAVERI, SV
DIETRICH, G
HUREZ, V
KAZATCHKINE, MD
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 86 (02): : 192 - 198
[23] Adverse effects of treatment with intravenous immunoglobulins for neurological diseases
Matthias Wittstock
Uwe K. Zettl
Journal of Neurology, 2006, 253 : v75 - v79
[24] Intravenous use of trypaflavin in infectious diseases.
Bohland, K
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1919, 45 : 797 - 801
[25] INTRAVENOUS IMMUNOGLOBULINS IN THE TREATMENT OF AUTOIMMUNE-DISEASES AND SYSTEMIC INFLAMMATORY DISEASES
KAZATCHKINE, M
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1993, 35 (03): : 209 - 210
[26] The use of intravenous immunoglobulins in the treatment of neuromuscular disorders
Voltz, R
Hohlfeld, R
CURRENT OPINION IN NEUROLOGY, 1996, 9 (05) : 360 - 366
[27] NORMAL HUMAN POLYCLONAL IMMUNOGLOBULINS FOR INTRAVENOUS USE SIGNIFICANTLY DELAY HYPERACUTE XENOGRAFT REJECTION
LATREMOUILLE, C
HAEFFNERCAVAILLON, N
GOUSSEF, N
MANDET, C
HINGLAIS, N
BRUNEVAL, P
BARIETY, J
CARPENTIER, A
GLOTZ, D
TRANSPLANTATION PROCEEDINGS, 1994, 26 (03) : 1285 - 1285
[28] Intravenous immunoglobulins in neurological diseases
Uwe K. Zettl
Eilhard Mix
Journal of Neurology, 2006, 253 : v1 - v1
[29] Intravenous immunoglobulins in neurological diseases
Zettl, Uwe K.
Mix, Eilhard
JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 5) : 1 - 1
[30] ACTION MECHANISMS OF INTRAVENOUS IMMUNOGLOBULINS IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
MOUTHON, L
HUREZ, V
KAZATCHKINE, M
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE, 1994, 34 (02): : 207 - 210

← 1 2 3 4 5 →